Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: harsh (4), strict (49), acute (409)

Pneumatic retionopexy - patient information

Description: Your doctor has recommended that you have a procedure called a pneumaticretinopexy to treat your retinal detachment. We hope this factsheet
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Pneumatic-retionopexy-3432-PIL.pdf

Hand therapy treatment for children with camptodactyly - patient information

Description: This factsheet explains what camptodactyly is and the types of hand therapy treatment available for children.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Hand-therapy-treatment-for-children-with-camptodactyly-3474-PIL.pdf

Azathioprine to treat neurological diseases - patient information

Description: This factsheet contains information about the use of azathioprine to treat neurological diseases, including how the treatment is given and the
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Azathioprine-to-treat-neurological-diseases-3153-PIL.pdf

Mobocertinib

Description: A chemotherpay document based on Mobocertinib.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Mobocertinib.pdf

DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1

Description: Details of the Chemotherapy Protocol for Myeloma.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-T-SC-Bortezomib-Daratumumab-Dexamethasone-Thalidomide.pdf

CCP-UK Patient Data Notification v0.2 05MAY2022

Description: _______________________________________________ CCP-UK Patient Data Notification _______________________________________________ The purpose
Url: /Media/Southampton-Clinical-Research/Downloads/CCP-UK-Patient-Data-Notification-v0.2-05MAY2022.pdf

Alectinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ALECTINIB Regimen • NSCLC - ALECtinib Indication • Alectinib (as monotherapy) is ind
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Alectinib.pdf

Rituximab SC (8 weekly) Ver 1

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (8 weekly) Regimen Lymphoma – Rituximab SC (8 weekly) Indication Maintenance single agent therapy in previously u
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-8-weekly-Ver-1.pdf

Rituximab SC (12 weekly) Ver1

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (12 weekly) Regimen Lymphoma – Rituximab SC (12 weekly) Indication Maintenance single agent therapy in relapsed /
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-12-weekly-Ver1.pdf

Rituximab (8 weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma as first-line maintenance th
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

271 to 280 of 726

Previous … 26 27 28 29 30 … Next